Ask AI

The APP’s Guide to Patient-Centered Management of CDK4/6 Inhibitor Therapy for HR+/HER2- Breast Cancer

Share

Program Content

Activities

  • APP Guide CDK46i Therapy
    The APP’s Guide to Patient-Centered Management of CDK4/6 Inhibitor Therapy for HR+/HER2- Breast Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 19, 2025

  • Managing CDKi Therapy in HR Positive HER2 Negative BC
    The APP’s Guide to Patient-Centered Management of CDK4/6 Inhibitor Therapy for HR+/HER2- Breast Cancer
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 03, 2025

    Expires: April 02, 2026

  • Applying CDK46i in EBC
    Applying CDK4/6 Inhibitors in High-Risk Early HR+/HER2- Breast Cancer: A Case-Based Discussion
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 06, 2025

Supporters

Supported by an educational grant from Lilly.

Lilly